Long Path Partners LP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 31, 2026), Long Path Partners LP reported 10 stock positions worth $234.6 million. Its top holding was Ncino (NCNO) at 25.4% of the portfolio, followed by Mesa Laboratories (MLAB, 20.2%) and Alkami Technology (ALKT, 17.3%). Compared with Q1 2026, it opened 1 new position, added to 4 and reduced 5. The biggest buy was Alkami Technology (ALKT, shares +24%) and the biggest sale I3 Verticals Class A (IIIV, shares −74%).
- Most Recent 13F
- Q2 2026
- Location
- Stamford, CT
- CIK
- 0001905112
- Portfolio Value
- $234.6M (Q2 2026)
- SEC Filing
- 0000919574-26-004718 ↗ filed Jul 31, 2026
Holdings Value
Holdings 10 stocks · $234.6M
| NCNO Ncino Inc. | 25.36% | 3,639,442 | $59.5M | Reduce -17.7% |
| MLAB Mesa Laboratories Inc. | 20.24% | 477,126 | $47.5M | Add +17.6% |
| ALKT Alkami Technology Inc. | 17.29% | 2,239,524 | $40.6M | Add +24.5% |
| CPAY Corpay Inc. | 12.42% | 87,472 | $29.2M | Reduce -0.9% |
| TYL Tyler Technologies Inc. | 7.81% | 62,642 | $18.3M | Add +3.9% |
| SPSC SPS Commerce Inc. | 4.41% | 180,912 | $10.3M | New |
| VEEV Veeva Systems Inc. Class A | 3.99% | 52,738 | $9.4M | Add +60.3% |
| TDG Transdigm Group Inc. | 3.45% | 6,078 | $8.1M | Reduce -6.2% |
| PCOR Procore Technologies Inc. | 3.06% | 176,896 | $7.2M | Reduce -15.4% |
| IIIV I3 Verticals Inc. Class A | 1.96% | 215,319 | $4.6M | Reduce -73.7% |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $234.6M | NCNO, MLAB, ALKT, CPAY, TYL |
| Q1 2026 | 9 | $220.1M | NCNO, MLAB, ALKT, CPAY, TYL |
| Q4 2025 | 7 | $292.4M | NCNO, ALKT, CPAY, IIIV, DCBO |
| Q3 2025 | 7 | $276.6M | NCNO, ALKT, CPAY, IIIV, DCBO |
| Q2 2025 | 6 | $294.6M | NCNO, CPAY, DCBO, ALKT, IIIV |
| Q1 2025 | 10 | $258.7M | NCNO, PCOR, CPAY, DCBO, IIIV |
| Q4 2024 | 11 | $308.6M | NCNO, PCOR, DCBO, CRM, CPAY |
| Q3 2024 | 10 | $308.3M | NCNO, CPAY, DCBO, CRM, LBRDK |
| Q2 2024 | 10 | $252.3M | NCNO, CPAY, DCBO, PCOR, ALKT |
| Q1 2024 | 9 | $190.0M | CPAY, NCNO, ALKT, CRM, DCBO |